Dr. Kartik Krishnan was named Chief Executive Officer in 2024, having previously served as OncoNano’s President, Head of Research and Development and Chief Medical Officer since joining the company in 2022. Kartik is an accomplished biotechnology executive focused on corporate excellence and execution. He has over 20 years of hands-on experience in developing experimental cancer therapeutics as an investigator and sponsor. Prior to joining OncoNano, Kartik served as Chief Medical Officer of Arcus Biosciences where he oversaw a diverse portfolio of biologics and small molecules across multiple phases of development, ranging from first-in-human to Phase 3. Prior to Arcus, he held clinical development and pharmacovigilance roles at Astex, FivePrime Therapeutics, BioMarin, Genentech, Roche and Amgen. Kartik previously worked in academia, holding a faculty position at the University of Arizona with both clinical and primary research responsibilities. Kartik received his bachelor’s degree in history (with Distinction) from the University of Virginia and completed his Doctor of Medicine and Doctor of Philosophy in cellular, molecular and biophysical studies at Columbia University’s College of Physicians and Surgeons. He trained in pediatrics at the University of California, Los Angeles, and in pediatric hematology and oncology at Johns Hopkins University and the National Cancer Institute.